What is Ocular Biomarker?

A biomarker is an objectively measured and assessed characteristic that can be used to examine normal biological or pathological processes and is widely used in drug development in clinical settings to better understand the effectiveness of ocular disease treatments. An ideal biomarker should besafe and easily measurable, changeable through treatment, and consistent across gender and racial groups. Biomarkers in the eye have the advantage of obtaining a variety of ocular substrates through minimally invasive methods,which repeated sampling for biomarker assessment enables reproducible objective measurements of disease processes or biological responses to drug treatments. Ocular biomarkers play an important role in improving the drug development process as well as in biomedical research. In molecular terms it is are a subset of markers that can be discovered using genomics, proteomics techniques, or imaging techniques.

Fig. 1. Anatomical representation of ocular biomarkers. (Lim J K, et al., 2021)

Our Services

Biomarkers are a crucial prerequisite for drug development. They are often involved in several ways, including measuring disease progression and evaluating the most effective treatment options for a particular disease type. Ace Therapeutics has a team of high-quality bioscientists to provide you with comprehensive global eye biomarker services, covering multiple tests such as screening, discovery, identification, transformation and analysis of biomarkers. In addition, we can also provide technical support for clinical transformation to increase the development of candidate drugs.

At Ace Therapeutics, we have created a unique knowledge framework for biomarker analysis that can help you make the best decisions quickly, thereby minimizing costs and reducing risks.

With the help of proteomics, genomics, transcriptomics, etc., our professional team utilizes flow cytometry for cell function and phenotype analysis and biomarker expression, ELISA-based cytokine and chemokine analysis and mass spectrometry-based proteomic analysis and other technical means to accelerate the development of drugs.

Our expertise enables us to assist you in the discovery, analysis and linking of ocular biomarkers to drug development, providing biomarkers perfectly adapted to your use. Here we provide the following ocular biomarker services including, but not limited to.

Ocular Biomarker Services

Advantages of Ocular Biomarker Services

• Has a variety of detection, analysis and identification platforms for ocular biomarkers.
• Exploratory biomarker research is suitable.
• Validate differences according to different research purposes and methods.
• Significant levels of endogenous biomarkers.

Comprehensive, systematic biomarker services help accelerate the drug development process. Ace Therapeutics' biomarker service team will provide you with the most suitable solution based on your project's specific requirements. Our scientists are always ready to answer your questions. If you are interested in our services, please feel free to contact us.

Reference

1. Lim J K, Li Q X, He Z, et al. The Eye As a Biomarker for Alzheimer's Disease. Front Neurosci. 2016;10:536.

• Customized In Vivo Ocular Models
• Ophthalmic Drug Discovery Services
• Preclinical Ophthalmic Drug Development Services
• Therapeutic Areas in Ophthalmology

• * Name:
• Phone:
• * Email:
• * Services or Products of Interest:
• Project Description:
• * All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

  * Tick to confirm the Research Use Only (RUO) statement.

• Submit